Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community

Launched by XIUJUAN ZANG · Apr 18, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how common hyperkalemia, which is a condition where potassium levels in the blood are too high, is among patients with chronic kidney disease (CKD) who are not on dialysis. Researchers want to find out how many people in this group have hyperkalemia and what factors might increase their risk of developing it. To gather this information, the study will collect blood samples and ask participants about their health and lifestyle at 18 community health centers. The goal is to use the findings to create a tool that helps doctors better screen for and manage hyperkalemia in primary care settings.

To participate in this study, individuals need to be 18 years or older and have a stable health condition, including specific vital signs. They should also have a confirmed diagnosis of CKD. However, those with certain serious health issues, like recent heart problems or severe diabetic complications, will not be able to join. Participants can expect to provide blood samples and answer questions about their health during the study. This research aims to improve the care and support for people living with chronic kidney disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Aged 18 years or older with stable vital signs, specifically defined as:
• • 1. Body temperature: 36.0°C-38.0°C;
• • 2. Pulse: 50-120 beats/min;
• • 3. Respiratory rate: 10-24 breaths/min;
• • 4. Blood pressure: Systolic blood pressure ≥90 mmHg and diastolic blood pressure ≥60 mmHg.
• • Willing to participate in the study and sign the informed consent form.
• • Hematocrit (Hct) level between 25% and 60%.
• • Confirmed diagnosis of chronic kidney disease (CKD).
• Exclusion Criteria:
• • Patients in the unstable phase of acute cardiovascular or cerebrovascular diseases (e.g., acute cerebral infarction, cerebral hemorrhage, or acute coronary syndrome).
• • Patients in the unstable phase of severe acute diabetic complications (e.g., diabetic ketoacidosis or hyperosmolar hyperglycemic coma).
• • Patients currently in the acute kidney injury (AKI) stage.
• • Patients who have started renal replacement therapy.
• • Pregnant or breastfeeding women.
• • Patients currently participating in or who have participated in other clinical trials within the past six months.
• • Patients unable to understand verbal or written instructions, including informed consent content.
• • Patients unable to cooperate with the study procedures.
• • Other conditions deemed unsuitable for participation in this clinical trial by the investigator.